Exact Sciences Schedules Third Quarter 2024 Earnings Call
2024年10月8日 - 7:00PM
ビジネスワイヤ（英語）
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, today announced that the
company plans to release its third quarter 2024 financial results
after the close of the U.S. financial markets on November 5, 2024.
Following the release, company management will host a webcast and
conference call at 5 p.m. ET to discuss financial results and
business progress.
Third quarter 2024 webcast & conference call details
Date:
Tuesday, November 5, 2024
Time:
5 p.m. ET
Webcast:
The live webcast can be accessed at
www.exactsciences.com
Telephone:
Domestic callers, dial
888-330-2384
International callers, dial +1
240-789-2701
Access code for both domestic and
international callers: 4437608
A replay of the webcast will be available at
www.exactsciences.com. The webcast, conference call, and replay are
open to all interested parties.
About Exact Sciences Corp. A leading provider of cancer
screening and diagnostic tests, Exact Sciences gives patients and
health care professionals the clarity needed to take life-changing
action earlier. Building on the success of the Cologuard® and
Oncotype® tests, Exact Sciences is investing in its pipeline to
develop innovative solutions for use before, during, and after a
cancer diagnosis. For more information, visit ExactSciences.com,
follow Exact Sciences on X @ExactSciences, or find Exact Sciences
on LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241008746549/en/
Erik Holznecht Exact Sciences Corp.
investorrelations@exactsciences.com 608-800-6605
EXACT Sciences (NASDAQ:EXAS)
過去 株価チャート
から 9 2024 まで 10 2024
EXACT Sciences (NASDAQ:EXAS)
過去 株価チャート
から 10 2023 まで 10 2024
